Neoadjuvant Immunotherapy for Localized Pancreatic Cancer: Challenges and Early Results

SIMPLE SUMMARY: Pancreatic cancer is a deadly disease with limited effective treatments. Despite growing interest in immunotherapy for other cancer types, immunotherapy has not shown significant utility in metastatic pancreatic cancer. However, investigators are examining the role of immunotherapy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chick, Robert Connor, Gunderson, Andrew J., Rahman, Shafia, Cloyd, Jordan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416846/
https://www.ncbi.nlm.nih.gov/pubmed/37568782
http://dx.doi.org/10.3390/cancers15153967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416846/
https://www.ncbi.nlm.nih.gov/pubmed/37568782
http://dx.doi.org/10.3390/cancers15153967

Ejemplares similares